BioSphere Medical Schedules First Quarter 2008 Financial Results Release and Conference Call

BioSphere Medical Supports ACOG Committee Opinion on Surgery and Patient Choice

BioSphere Medical Highlights Patient and Economic Benefits When Ob/Gyns and Interventional Radiologists Collaborate

BioSphere Medical to Present at B. Riley's 9th Annual Las Vegas Investor Conference

BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China

BioSphere Medical Highlights Scheduled Presentations and Abstracts at the 2008 SIR 33rd Annual Scientific Meeting

BioSphere Medical Announces Appointment of Dr. Linda D. Bradley to Medical Advisory Board

BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development

BioSphere Medical to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference

BioSphere Medical Reports 2007 Fourth Quarter and Year-End Financial Results

BioSphere Medical Receives Market Clearance to Sell Embosphere(R) Microspheres in the People's Republic of China

BioSphere Medical Names Joel B. Weinstein Vice President of Global Marketing and Sales

Study Published in JVIR Concludes That Embosphere(R) Microspheres Should Be the Preferred Agent for Uterine Fibroid Embolization

BioSphere Medical Names Melodie R. Domurad, Ph.D., Vice President of Regulatory, Medical Affairs, and Quality Systems

BioSphere Medical to Present at Needham & Company LLC 10th Annual Growth Stock Conference

Three-Year Data Published in Obstetrics & Gynecology Demonstrates Long-Term Efficacy and Durability of Uterine Fibroid Embolization (UFE)

Three-Year Registry Data from 1,278 Women Shows Long-

BioSphere Medical and DuPont Applied Biosciences Sign Strategic Collaboration Agreement

BioSphere Medical Receives CE Mark Approval for Transarterial Chemoembolization Using HepaSphere(TM) Microspheres

BioSphere Medical Announces 113% Increase in CMS Hospital Outpatient Reimbursement Rate for Uterine Fibroid Embolization

BioSphere Medical to Present at Stephens Inc. Fall Investment Conference

BioSphere Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

BioSphere Medical to Present at A.G. Edwards' 2nd Annual Emerging Growth Conference 2007

BioSphere Medical to Present at Roth 2007 New York Conference

BioSphere Medical to Present at CIRSE 2007 Conference

BioSphere Medical to Present at Noble Financial Equity Conference

BioSphere Medical Schedules Second Quarter 2007 Financial Results Release and Conference Call

BioSphere Medical to Present at C.E. Unterberg, Towbin Emerging Growth Conference

BioSphere Medical Announces Departure of Chief Operating Officer

BioSphere Medical Reports First Quarter 2007 Financial Results

BioSphere Medical Schedules First Quarter 2007 Financial Results Release and Conference Call

Article Published in the Journal of Vascular and Interventional Radiology Supports Long-Term Efficacy and Durability of Embosphere Microspheres

BioSphere Medical Highlights a Scheduled Presentation and Abstracts at the 2007 SIR 32nd Annual Scientific Meeting

BioSphere Medical to Present at Roth Capital Partners 19th Annual OC Conference

BioSphere Medical Reports Fourth Quarter 2006 Financial Results

New England Journal of Medicine Study Finds UFE Provides Same QOL Benefit as Surgery with Less Recovery and Cost

BioSphere Medical Announces That a Live-Case and Scientific Presentation Featuring QuadraSphere Microspheres

BioSphere Medical Schedules Fourth Quarter and Year End 2006 Financial Results Release and Conference Call

BioSphere Medical Provides Update on Physician UFE Reimbursement Based on the CMS Preliminary Rule

BioSphere Medical Receives FDA Approval For QuadraSphere(TM) Microspheres

Research Reveals More Women with Fibroids Discussing Uterine Fibroid Embolization (UFE)

BioSphere Medical Reports Third Quarter 2006 Financial Results

BioSphere Medical to Present at Rodman & Renshaw's 8th Annual Healthcare Conference

BioSphere Medical to Present at C.E. Unterberg, Towbin Life Sciences Conference

BioSphere Medical Schedules Third Quarter 2006 Financial Results Release and Conference Call

BioSphere Medical's HepaSphere(TM) Microspheres to Be Featured at CIRSE 2006 Conference

FDA Clears BioSphere Medical's Next Generation EmboCath(R) Plus Infusion Microcatheter

BioSphere Medical Reports Second Quarter 2006 Financial Results

BioSphere Medical to Announce 2nd Quarter 2006 Earnings Results

Arterial Embolization Effective in Patients with Liver Cancer Recurrence

BioSphere Medical to Participate in Phase II Liver Cancer Study at The Johns Hopkins University School of Medicine

FDA Clears BioSphere Medical's Next Generation Sequitor(TM) Steerable Guidewire

Marian L. Heard Elected to BioSphere Medical's Board of Directors

BioSphere Medical to Present at Rodman and Renshaw 3rd Annual Global Healthcare Conference

BioSphere Medical Reports First Quarter 2006 Financial Results

BioSphere Medical To Announce 1st Quarter 2006 Earnings Results

BioSphere Medical Announces Three-Year Study Demonstrates Uterine Fibroid Embolization Effective and Safe

BioSphere Medical Announces Three-Year Study

BioSphere Medical Voluntarily Recalls HepaSphere™ Microspheres to Correct Package Defect

Less drastic treatment for uterine fibroids a safe alternative to surgery, study says

BioSphere Medical Reports Regulatory Approvals of EmboCath® and Segway® in China

One-Year Registry Data Shows High Rate of Significant Symptom Improvement and Patient Satisfaction